Grace Therapeutics GRCE Growth Metrics (2011-2026)

NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Grace Therapeutics Quarterly Growth Metrics

Periods 60 quarters
Latest Sep 2026

Grace Therapeutics reported asset growth of -9.64% for the quarter ended Sep 2026. These growth metrics cover 60 quarters of results from Aug 2011 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ)
298.25%35.68%-24.68%-99.87%-23.88%72,586.23%-75.78%258.97%16.43%-29.75%3.93%-15.13%-20.79%-18.75%132.31%-31.79%-47.57%68.52%-42.31%87.62%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
76.91%-69.89%-72.05%8.71%-16.71%2.34%5.07%-21.68%-0.98%-20.84%-23.51%-41.84%-13.73%-12.47%41.14%1.25%-7.25%11.56%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
21.27%-7.45%22.89%-90.36%-91.02%-45.17%-50.21%-11.28%134.33%10.22%15.87%21.01%-29.36%-40.46%-13.34%607.37%524.70%-17.32%10.42%-11.06%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
1,613.33%260.23%203.27%-99.49%-99.90%-47.73%-83.19%48,009.97%73,489.16%-28.88%205.13%-27.86%-50.92%-43.23%26.89%1.98%-32.50%40.00%-65.23%-4.37%
Revenue (QoQ)
-22.55%-30.22%44.88%10.87%-15.69%0.00%-19.77%2.17%
Revenue Growth (5y)
16.25%3.71%
Revenue Growth (3y)
Revenue Growth (1y)
-13.19%-5.49%35.43%-25.00%-30.88%
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.70M-0.05M-0.03M0.12M0.02M0.00M0.00M-0.08M-0.91M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
0.10M-0.02M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.19M0.62M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.14M-0.60M0.06M0.12M0.15M-0.05M-0.98M
Return on Equity [ROE] (QoQ)ROE (QoQ)
286.00131.00-160.00-620.00-77.000.00M0.00M194.00259.000.00M143.00-119.00-460.00858.0027.00347.00301.00-274.000.00M-523.00
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M0.01M0.03M0.05M0.02M0.06M0.36M0.06M0.02M0.01M0.00M0.00M-284.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.06M0.02M0.06M0.37M0.05M0.01M189.00-0.01M0.00M0.00M-697.000.00M-716.00-529.00438.00816.000.00M0.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M0.00M-363.00-725.000.00M-0.01M0.00M0.00M0.00M0.00M0.00M0.00M422.00306.00772.000.00M401.000.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
100.00-137.00-76.00-176.00-30.000.00M0.00M417.00264.000.00M-180.00-543.00-251.00155.00420.00291.00170.005.000.00M-342.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.01M0.00M0.00M0.00M-0.01M-0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.00M0.01M0.01M0.02M0.01M0.01M0.01M0.00M0.00M674.000.00M0.00M0.00M-764.00-297.00-97.000.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.01M0.00M0.00M-290.00-420.000.00M-0.01M-0.01M0.00M0.00M0.01M0.00M0.00M-820.00-220.00614.000.00M886.000.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
233.00179.00-77.00-509.00-57.000.00M0.00M186.00303.000.00M119.00-118.00-394.00676.00-18.00308.00261.00-268.000.00M-509.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.00M0.00M0.00M-515.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.01M0.01M0.01M0.02M0.01M0.00M0.00M-0.01M0.00M0.00M-498.000.00M-628.00-569.00247.00566.000.00M0.00M0.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M-173.00-463.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M283.00146.00572.000.00M283.000.00M0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-102.40%2,133.33%-8.20%-7.14%-19.23%-88.10%20.00%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-14.90%-43.68%-44.94%-45.63%-48.15%-66.38%-64.76%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-50.76%-26.00%-61.96%-62.80%-62.10%-64.80%-69.91%-68.28%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-34.38%-101.55%-58.40%1,500.00%-91.80%-89.29%
Operating Margin (QoQ)
-0.05M-0.03M0.12M0.02M0.00M0.00M-0.08M-0.91M
Operating Margin Growth (5y)
0.10M-0.02M
Operating Margin Growth (3y)
Operating Margin Growth (1y)
0.06M0.12M0.15M-0.05M-0.98M
Operating Income (QoQ)Op. Inc (QoQ)
-25.43%1.59%-7.43%-7.99%16.90%-796.89%88.30%53.03%-45.46%-7.23%-52.10%2.66%23.33%14.07%2.92%18.16%3.16%-22.91%-428.80%85.60%
Operating Income Growth (5y)Op. Inc Growth (5y)
-17.84%-7.87%-319.54%-495.48%-264.03%-210.85%-234.08%20.82%9.12%5.04%9.63%4.61%5.60%20.64%-4.51%-5.53%-38.31%8.47%
Operating Income Growth (3y)Op. Inc Growth (3y)
-748.97%25.12%16.09%6.53%11.60%-111.38%-2.62%36.14%-15.71%-12.36%-16.42%-10.64%6.10%10.25%13.23%20.89%16.75%57.08%-52.89%-3.09%
Operating Income Growth (1y)Op. Inc Growth (1y)
-127.80%-91.43%-50.40%-43.20%5.12%-764.71%5.84%59.04%28.32%91.43%-11.43%-130.93%-21.72%2.45%37.74%47.65%33.88%5.44%-415.11%9.37%
Net Margin (QoQ)
-0.08M-0.14M0.36M-0.20M0.11M-0.08M0.05M-1.03M
Net Margin Growth (5y)
0.26M0.41M
Net Margin Growth (3y)
Net Margin Growth (1y)
-0.05M0.13M0.19M-0.12M-0.96M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-485.12%-3.34%-15.88%-8.95%21.10%-647.93%86.17%18.64%26.95%-32.41%17.34%-31.14%-21.07%115.31%-628.62%72.10%-146.80%49.11%-1,240.41%86.50%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-16.97%-324.07%-281.94%-438.22%-270.63%-185.07%-269.05%24.18%21.62%30.50%19.28%-47.93%6.35%31.34%6.39%26.91%-38.33%-33.07%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-926.53%32.40%20.03%38.47%31.54%-55.37%4.82%18.94%9.45%17.54%5.67%-76.50%-3.22%29.32%9.42%42.48%15.88%65.66%-57.74%13.33%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-17.33%30.85%-45.09%-602.45%-2.94%-645.06%11.07%33.60%38.52%89.12%34.95%-4.86%-73.78%120.09%-28.47%72.67%44.28%-285.22%-369.66%-127.19%
Net Income (QoQ)
-485.12%-3.34%-15.88%-8.95%21.10%-647.93%86.17%18.64%26.95%-32.41%17.34%-31.14%-21.07%115.31%-628.62%72.10%-146.80%49.11%-1,240.41%86.50%
Net Income Growth (5y)
-16.97%-6.52%4.06%-35.19%6.90%28.39%7.30%39.59%21.62%30.50%19.28%15.15%6.35%31.34%6.39%26.91%-38.33%-33.07%
Net Income Growth (3y)
-2.65%53.71%20.03%38.47%31.54%-4.47%4.82%18.94%9.45%17.54%5.67%-76.50%-3.22%29.32%9.42%42.48%15.88%65.66%-57.74%13.33%
Net Income Growth (1y)
-17.33%30.85%-45.09%-602.45%-2.94%-645.06%11.07%33.60%38.52%89.12%34.95%-4.86%-73.78%120.09%-28.47%72.67%44.28%-285.22%-369.66%-127.19%
Net Cash Flow (QoQ)NCF (QoQ)
-23.26%22.18%356.13%-142.68%-154.61%119.10%-474.55%185.83%-257.69%152.81%-180.96%-17.39%3.28%370.20%-119.21%-47.70%157.59%-193.65%-90.03%334.55%
Net Cash Flow Growth (5y)NCF Growth (5y)
47.68%-14.99%-28.63%19.78%-30.43%24.73%-20.12%24.96%-23.20%-25.49%-65.12%54.48%3.70%-32.25%-33.73%-15.65%20.79%33.95%
Net Cash Flow Growth (3y)NCF Growth (3y)
-30.82%9.72%102.56%-42.59%-196.69%44.58%-34.41%107.18%-37.45%-43.33%29.55%-9.07%-0.60%76.89%-31.33%2.83%30.21%-44.50%19.78%12.15%
Net Cash Flow Growth (1y)NCF Growth (1y)
-128.44%-112.79%177.72%-4.87%-116.61%153.16%-177.74%256.33%3.18%167.71%42.13%-179.14%51.46%148.39%41.07%25.86%144.15%-115.30%-51.36%340.38%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Income After Tax (QoQ)
-485.12%-3.34%-15.88%-8.95%21.10%-647.93%86.17%18.64%26.95%-32.41%17.34%-31.14%-21.07%115.31%-628.62%72.10%-146.80%49.11%-1,240.41%86.40%
Income After Tax Growth (5y)
-16.04%-6.41%-32.19%-432.72%-256.70%-239.96%-218.35%21.30%18.02%10.95%7.39%16.63%3.87%34.89%-3.75%12.53%-38.33%-33.17%
Income After Tax Growth (3y)
-702.44%28.06%13.82%7.01%13.93%-93.24%0.60%25.82%-7.48%-11.24%5.67%-76.50%-3.22%29.32%9.42%42.48%15.88%65.66%-57.74%13.11%
Income After Tax Growth (1y)
-96.16%-69.74%-45.09%-602.45%-2.94%-645.06%11.07%33.60%38.52%89.12%34.95%-4.86%-73.78%120.09%-28.47%72.67%44.28%-285.22%-369.66%-128.89%
Gross Profit (QoQ)
Gross Profit Growth (3y)
Gross Profit Growth (1y)
Gross Margin (QoQ)
Gross Margin Growth (3y)
Gross Margin Growth (1y)
Free Cash Flow (QoQ)FCF (QoQ)
24.90%31.39%-72.75%36.66%-8.17%10.42%-87.16%66.14%10.46%-11.52%-70.43%-17.88%2.93%28.21%39.03%-74.51%29.05%23.99%-90.03%44.61%
Free Cash Flow Growth (5y)FCF Growth (5y)
-36.37%-16.98%-1.87%3.91%-8.54%15.18%23.90%24.91%12.07%7.23%10.97%33.82%15.60%5.68%11.95%0.75%1.08%21.81%
Free Cash Flow Growth (3y)FCF Growth (3y)
14.80%29.15%7.40%17.68%20.32%47.67%-14.06%20.54%23.43%-6.23%-1.88%11.44%3.53%2.07%30.79%2.97%15.70%20.19%19.78%5.49%
Free Cash Flow Growth (1y)FCF Growth (1y)
-8.78%-78.69%-59.75%43.63%18.80%-6.01%-14.85%38.59%49.17%36.71%42.37%-100.62%-117.49%-40.00%49.92%25.86%45.81%42.62%-78.85%43.24%
FCF Margin (QoQ)
-0.08M-0.09M0.16M0.07M-0.09M0.05M0.01M-0.11M
FCF Margin Growth (5y)
0.39M0.03M
FCF Margin Growth (3y)
FCF Margin Growth (1y)
0.06M0.05M0.19M0.04M-0.14M
EPS (Diluted) (QoQ)
-385.12%-24.22%3.69%-8.41%21.21%-647.93%86.17%19.90%52.05%-59.89%27.93%-24.56%-21.07%114.57%-501.24%72.10%-132.09%47.81%-1,181.47%88.41%
EPS (Diluted) Growth (5y)
33.30%-141.58%-117.52%-252.78%-142.93%-86.27%-121.67%43.39%43.06%50.02%41.96%-62.26%35.51%52.41%30.75%42.86%-4.95%-20.97%
EPS (Diluted) Growth (3y)
-408.94%51.90%46.50%58.91%54.30%-36.96%34.13%43.57%37.67%34.30%30.66%-54.13%10.98%27.71%29.88%55.40%36.06%73.68%-19.11%37.47%
EPS (Diluted) Growth (1y)
40.36%45.73%14.74%-469.79%-2.19%-515.28%11.64%34.72%60.27%91.51%55.74%31.17%-73.78%115.84%11.84%80.25%62.14%-235.60%-333.07%-79.84%
EPS (Basic) (QoQ)
-385.12%-24.22%3.69%-8.41%21.21%-647.93%86.17%19.90%52.05%-59.89%27.93%-24.56%-21.07%114.57%-501.24%72.10%-132.09%47.81%-1,181.47%88.41%
EPS (Basic) Growth (5y)
41.50%-111.87%-90.77%-194.43%-102.75%-55.46%-85.01%50.49%46.37%52.41%44.25%-64.57%38.85%54.74%37.20%50.01%-4.95%-20.97%
EPS (Basic) Growth (3y)
-276.54%61.54%51.60%62.13%57.28%-34.16%39.71%48.11%47.04%47.41%30.66%-54.13%10.98%27.71%29.88%55.40%36.06%73.68%-19.11%37.47%
EPS (Basic) Growth (1y)
63.42%72.17%14.74%-469.79%-2.19%-515.28%11.64%34.72%60.27%91.51%55.74%31.17%-73.78%115.84%11.84%80.25%62.14%-235.60%-333.07%-79.84%
EBT (QoQ)
-485.12%-20.49%-4.70%-6.67%18.12%-811.79%88.64%13.75%30.12%-56.02%17.61%-28.23%-11.11%91.97%-780.10%72.10%-146.80%-24.32%-448.64%86.45%
EBT Margin (QoQ)
-0.09M-0.14M0.35M-0.14M0.11M-0.08M-0.07M-0.91M
EBT Margin Growth (5y)
0.10M-0.01M
EBT Margin Growth (3y)
EBT Margin Growth (1y)
-0.02M0.18M0.24M-0.19M-0.96M
EBT Growth (5y)
-17.26%-7.07%-34.00%-461.83%-261.68%-248.75%-223.71%17.30%13.92%6.92%4.84%37.58%3.87%34.89%-3.75%-4.59%-38.33%-33.12%
EBT Growth (3y)
-702.44%24.28%12.31%6.05%11.96%-111.17%-1.73%22.60%-10.51%-20.81%-2.33%-85.34%-8.01%56.22%10.98%43.07%17.77%57.68%-54.13%16.84%
EBT Growth (1y)
-96.16%-97.91%-52.85%-618.25%-10.19%-733.88%9.53%26.85%37.57%89.32%22.52%-15.19%-83.15%90.58%-0.63%78.10%51.37%-653.40%-369.66%-128.04%
EBIT (QoQ)
-25.43%1.59%-7.43%-7.99%16.90%-796.89%88.30%53.03%-45.46%-7.23%-52.10%2.66%23.33%14.07%2.92%18.16%3.16%-22.91%-428.80%85.60%
EBIT Margin (QoQ)
-0.05M-0.03M0.12M0.02M0.00M0.00M-0.08M-0.91M
EBIT Margin Growth (5y)
0.10M-0.02M
EBIT Margin Growth (3y)
EBIT Margin Growth (1y)
0.06M0.12M0.15M-0.05M-0.98M
EBIT Growth (5y)
-17.84%-7.87%-319.54%-495.48%-264.03%-210.85%-234.08%20.82%9.12%5.04%9.63%4.61%5.60%20.64%-4.51%-5.53%-38.31%8.47%
EBIT Growth (3y)
-748.97%25.12%16.09%6.53%11.60%-111.38%-2.62%36.14%-15.71%-12.36%-16.42%-10.64%6.10%10.25%13.23%20.89%16.75%57.08%-52.89%-3.09%
EBIT Growth (1y)
-127.80%-91.43%-50.40%-43.20%5.12%-764.71%5.84%59.04%28.32%91.43%-11.43%-130.93%-21.72%2.45%37.74%47.65%33.88%5.44%-415.11%9.37%
EBITDA Margin (QoQ)
-0.05M-0.03M0.12M0.02M0.00M0.00M-0.08M-0.91M
EBITDA Margin Growth (5y)
0.10M-0.02M
EBITDA Margin Growth (3y)
EBITDA Margin Growth (1y)
0.06M0.12M0.15M-0.05M-0.98M
Cash from Operations (QoQ)Cash from Ops. (QoQ)
24.90%31.39%-72.53%36.62%-8.23%10.64%-87.61%66.14%10.46%-10.36%-72.22%-17.88%2.93%28.21%39.03%-74.51%29.05%23.99%-90.03%44.61%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-34.69%-15.92%-1.22%0.74%-7.41%15.86%24.18%39.03%12.03%7.18%10.35%33.63%15.45%5.53%11.95%0.75%1.08%21.81%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
15.32%49.75%7.36%17.62%19.38%47.47%-14.39%20.33%23.43%-5.86%-1.88%11.44%3.53%2.07%30.76%2.96%15.70%20.12%19.78%5.49%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-8.78%-78.69%-59.54%43.66%18.80%-5.76%-15.00%38.56%49.17%37.22%42.37%-100.62%-117.49%-41.48%49.92%25.86%45.81%42.62%-78.85%43.24%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-80.37%-98.03%120,427.27%-100.72%-5,109.38%199.82%-6,058.18%199.91%-100.23%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
194.65%-9.64%-117.34%121.48%22.35%12.45%21.92%-14.90%15.36%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
26.90%26.02%33.94%-26.59%-143.36%-15.03%74.72%-68.42%40.58%87.06%-70.03%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
140.60%100.13%291.40%-103.38%-997.85%45,281.82%214.58%-31.05%31.17%100.23%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-10.60%-8.10%26.49%-8.99%-24.87%6.23%-22.39%24.77%-31.29%24.05%-15.70%-21.86%-27.05%100.21%-91.33%779.14%10.73%-9.08%-18.97%54.92%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
45.80%52.14%21.46%34.30%17.40%42.59%6.53%3.95%-4.92%-8.11%9.22%-30.84%7.86%-6.80%-19.73%-19.61%-10.41%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
21.85%33.92%21.44%15.86%25.09%21.30%32.69%-11.27%-23.28%-22.07%-25.69%-30.56%-9.98%-63.17%-21.55%-10.72%-15.24%-14.01%-7.57%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
24.36%-40.44%-6.34%-5.42%-20.51%-8.12%-43.63%-22.72%-29.33%-17.47%-10.35%-43.85%-40.39%-3.79%-90.11%11.26%68.90%-23.30%617.21%26.38%
Capital Expenditures (QoQ)Capex (QoQ)
-71.43%
Capital Expenditures Growth (5y)Capex Growth (5y)
15.96%15.19%-58.09%-47.16%
Capital Expenditures Growth (3y)Capex Growth (3y)
-28.31%-51.00%-70.73%
Capital Expenditures Growth (1y)Capex Growth (1y)
175.00%
Assets (QoQ)
-4.65%12.60%-2.87%-3.22%-3.40%-32.26%-7.70%7.09%-2.59%-3.79%-4.89%-6.27%-6.31%17.59%-3.04%-4.63%2.87%-2.68%-24.88%15.23%
Assets Growth (5y)
48.43%50.07%39.86%34.74%29.18%38.62%11.71%15.22%18.82%17.98%15.51%25.80%28.22%36.93%17.71%1.31%-3.70%-13.59%
Assets Growth (3y)
37.65%52.75%61.91%61.71%57.72%51.28%53.63%78.15%35.98%5.48%4.87%-18.29%-18.77%-17.59%-17.64%-18.04%-16.30%-5.56%-11.82%-9.64%
Assets Growth (1y)
276.95%105.93%106.66%0.93%2.25%-38.48%-41.54%-35.32%-34.77%-7.36%-4.54%-16.44%-19.64%-1.78%0.12%1.88%11.86%-7.42%-28.27%-13.34%

Grace Therapeutics Growth Metrics API

Pull Grace Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRCE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY